Up-regulation of the CYP1 family in rat and human liver by the aliphatic isothiocyanates erucin and sulforaphane

Toxicology

Volumn 252, Issue 1-3, 2008, Pages 92-98

  Hanlon, Natalya ^a   Coldham, Nick ^b   Sauer, Maurice J ^b   Ioannides, Costas ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Chemoprevention; Cytochrome P450; Erucin; Isothiocyanates; Precision cut slices; Sulforaphane

Indexed keywords

APOPROTEIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 3A4; ERUCIN; ISOTHIOCYANIC ACID; PENTOXYRESORUFIN; SULFORAPHANE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DIET; HUMANS; LIVER; MALE; RATS; RATS, WISTAR; SPECIES SPECIFICITY; SULFIDES; THIOCYANATES; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 53249140296     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.08.002     Document Type: Article

References (53)

1. Ambrosone C.B., McCann S.E., Freudenheim J.L., Marshall J.R., Zhang Y., and Shields P.G. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, but is not modified by GST genotype. J. Nutr. 134 (2004) 1134-1138
2. Ayalogu E.O., Snelling J., Lewis D.F.V., Talwar S., Clifford M.N., and Ioannides C. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim. Biophys. Acta 1272 (1995) 89-94
3. Barcelo S., Gardiner J.M., Gescher A., and Chipman J.K. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17 (1996) 277-282
4. Barillari J., Canistro D., Paolini M., Ferroni F., Pedulli G.F., Iori R., and Valgimigli L. Direct antioxidant activity of purified glucoerucin, the dietary secondary metabolite contained in rocket (Eruca sativa Mill.) seeds and sprouts. J. Agric. Food Chem. 53 (2005) 2475-2482
5. Bheemreddy R.M., and Jeffery E.H. The metabolic fate of purified glucoraphanin in F344 rats. J. Agric. Food Chem. 55 (2007) 2861-2866
6. Boyd G.W., Coombs M.M., and Ioannides C. Induction, binding to the hepatic aromatic hydrocarbon receptor and mutagenicity of a series of 11-alkoxy cyclopenta[a]phenanthren-17-ones: a structure activity relationship. Toxicology 95 (1995) 27-35
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Burke M.D., and Mayer R.T. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2 (1974) 583-588
9. Burke M.D., and Mayer R.T. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal and cytochrome P450 binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem. Biol. Interact. 45 (1983) 243-258
10. Cheung Y.L., Gray T.J., and Ioannides C. Mutagenicity of chrysene, its methyl and benzo derivatives, and their interactions with cytochromes P-450 and the Ah-receptor; relevance to their carcinogenic potency. Toxicology 81 (1993) 69-86
11. Cheung Y.-L., Snelling J., Mohammed N.N.D., Gray T.J.B., and Ioannides C. Interaction with the aromatic hydrocarbon receptor, CYP1A induction, and mutagenicity of a series of diaminotoluenes: implications for their carcinogenicity. Toxicol. Appl. Pharmacol. 139 (1996) 203-211
12. Chung F.-L., Conaway C.C., Rao C.V., and Reddy B.S. Chemoprevention of aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 21 (2000) 2287-2291
13. Conaway C.C., Jiao D., and Chung F.L. Inhibition of rat liver cytochrome P450 enzymes by isothiocyanates and their conjugates: a structure-activity relationship study. Carcinogenesis 17 (1996) 2423-2427
14. Conaway C.C., Yang Y.-m., and Chung F.-L. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr. Drug Metab. 3 (2002) 233-255
15. Denison M.S., and Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 309-334
16. Edwards R.J., Price R.J., Watts P.S., Renwick A.B., Tredger J.M., Boobis A.R., and Lake B.G. Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab. Dispos. 31 (2003) 282-288
17. Fahey J.W., Haristoy X., Dolan P.M., Kensler T.W., Scholtus I., Stephenson K.K., Talalay P., and Lozniewski A. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl. Acad. Sci. 99 (2002) 7610-7615
18. Goosen T.C., Mills D.E., and Hollenberg P.F. Effects of benzyl iosothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1. J. Pharmacol. Exp. Ther. 296 (2001) 198-206
19. Hanlon N., Coldham N., Gielbert A., Kuhnert N., Sauer M.J., King L.J., and Ioannides C. Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br. J. Nutr. 99 (2008) 559-564
20. Hanlon, N., Okpara, A., Coldham, N., Sauer, M.J., Ioannides, C. Modulation of rat hepatic and pulmonary cytochromes P450 and other xenobiotic-metabolising enzyme systems by the isothiocyanate erucin, a metabolite of sulforaphane. J. Agric. Food Chem., in press.
21. Hanlon, N., Poynton, C.L., Coldham, N., Sauer, M.J., Ioannides, C. The aliphatic isothiocyanates erucin and sulforaphane do not effectively up-regulate quinone reductase in human liver compared with rat. Mol. Nutr. Food Res., in press.
22. Harper P.A., Wong J.Y., Lam M.S., and Okey A.B. Polymorphisms in human AH receptor. Chem. Biol. Interact. 141 (2002) 161-187
23. Hashemi E., Dobrota M., Till C., and Ioannides C. Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures. Xenobiotica 29 (1999) 11-25
24. Hecht S.S. Inhibition of carcinogenesis by isothiocyanates. Drug Metab. Rev. 32 (2000) 395-411
25. Higdon J.V., Delage B., Williams D.E., and Dashwood R.H. Cruciferous vegetables and human cancer risk. Pharmacol. Res. 55 (2007) 224-236
26. Ioannides C., and Lewis D.F.V. Cytochromes P450 in the bioactivation of chemicals. Curr. Topics Med. Chem. 4 (2004) 1767-1788
27. Ioannides C., and Parke D.V. The cytochrome P450 I gene family of microsomal haemoproteins and their role in the metabolic activation of chemicals. Drug Metab. Rev. 22 (1990) 1-85
28. 2/M arrest and cell death in Caco-2 cells. Biochem. Pharmacol. 69 (2005) 1543-1552
29. Kassahun K., Davis M., Hu P., Martin B., and Baillie T. Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Chem. Res. Toxicol. 10 (1997) 1228-1233
30. Konsue, N., Ioannides, C. Tissue differences in the modulation of rat cytochromes P450 and phase II conjugation systems by dietary doses of phenethyl isothiocyanate, Food Chem. Toxicol., in Press.
31. Koyano S., Saito Y., Fukushima-Uesaka J., Ishida S., Ozawa S., Kamatani M., Minami H., Ohtsu A., Hamaguchi T., Shirao K., Yoshida T., Saijo N., Jinno H., and Sawada J.-I. Functional analysis of six aryl hydrocarbon receptor variants in a Japanese population. Drug Metab. Dispos. 33 (2005) 1254-1260
32. Lake B.G., Beamand J.A., Japenga A.C., Renwick A., Davies S., and Price R.J. Induction of cytochome P-450-dependent enzyme activities in cultured rat slices. Food Chem. Toxicol. 31 (1993) 377-386
33. Lee M.-S. Enzyme induction and comparative oxidative desulfuration of isothiocyanates to isocyanates. Chem. Res. Toxicol. 9 (1996) 1072-1078
34. Lerche-Langrand C., and Toutain H.J. Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 153 (2000) 221-253
35. Lesca P., Peryt B., Larrieu G., Alvinerie M., Galtier P., Daujat M., and Maurel P. Evidence for the ligand-independent inactivation of the AH receptor. Biochem. Biophys. Res. Commun. 209 (1995) 474-482
36. Lewis D.F.V., Ioannides C., and Parke D.V. Molecular dimensions of the substrate binding site of cytochrome P-448. Biochem. Pharmacol. 35 (1986) 2179-2185
37. Lewis D.F.V., Ioannides C., and Parke D.V. Structural requirements for substrates of cytochromes P-450 and P-448. Chem. Biol. Interact. 64 (1987) 39-60
38. Lin H.J., Probst-Hensch N.M., Louie A., Kau I.H., Witte J.S., Ingles S.A., Frank H.D., Lee E.R., and Haile R.W. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 647-652
39. London S.J., Yuan J.M., Chung F.L., Gao Y.T., Coetzee G.A., Ross R.K., and Yu M.C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung cancer risk: a prospective study in Shanghai, China. Lancet 356 (2000) 724-729
40. Lubet R.A., Mayer R.T., Cameron J.W., Nims R.N., Burke M.D., Wolf T., and Guengerich F. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238 (1985) 43-48
41. Machala M., Vondracek J., Blaha L., Ciganek M., and Neca J. Aryl hydrocarbon receptor-mediated activity of mutagemic polycyclic aromatic hydrocarbons determined using in vitro reporter gene assay. Mutat. Res. 497 (2001) 49-62
42. Maheo K., Morel F., Langouët S., Kramer H., Le Ferrec E., Ketterer B., and Guillouzo A. Inhibition of cytochrome P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 57 (1997) 3649-3652
43. Namkung M.J., Yang H.L., Hulla J.E., and Juchau M.R. On the substrate specificity of cytochrome P450IIIA1. Mol. Pharmacol. 34 (1988) 628-637
44. Pushparajah D.S., Umachandran M., Plant K.E., Plant N., and Ioannides C. Evaluation of the precision-cut liver and lung slice systems for the study of induction of CYP1, epoxide hydrolase and glutathione S-transferase activities. Toxicology 231 (2007) 68-80
45. Pushparajah D.S., Umachandran M., Nazir T., Plant K.E., Plant N., Lewis D.F.V., and Ioannides C. Up-regulation of CYP1A/B in rat lung and liver, and human precision-cut slices by a series of polycyclic aromatic hydrocarbons; association with the Ah locus and importance of molecular size. Toxicol. In Vitro 22 (2008) 128-145
46. Shen G., Khor T.O., Hu R., Yu S., Nair S., Ho C.T., Reddy B.S., Huang M.T., Newmark H.L., and Kong A.N. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res. 67 (2007) 9937-9944
47. Shu L., and Hollenberg P.F. Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: metabolic activation by cytochromes P450 2B1 and 2E1. Carcinogenesis 18 (1997) 801-810
48. Spitz M.R., Duphorne C.M., Detry M.A., Pillow P.C., Amos C.I., Lei L., de Andrade M., Gu X.J., Hong W.K., and Wu X.F. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1017-1020
49. Stresser D.M., Turner S.D., Blanchard A.P., Miller V.P., and Crespi C.L. Cytochrome P450 fluorimetric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab. Dispos. 30 (2002) 845-852
50. Yoxall V., Kentish P., Coldham N., Kuhnert N., Sauer M.J., and Ioannides C. Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: implications for its chemopreventive activity. Int. J. Cancer 117 (2005) 356-362
51. Zhang Y. Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat. Res. 555 (2004) 173-190
52. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., and Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. 91 (2004) 3147-3150
53. Zhao H., Grossman H.B., Hernandez L.M., Dinney C.P., and Wu X. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int. J. Cancer 120 (2007) 2208-2213